Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Johnson & Johnson

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Consumer Health Capital Expenditures

Consumer Health Capital Expenditures % Chg.

Consumer Health Capital Expenditures Common Size

Innovative Medicine Capital Expenditures

Innovative Medicine Capital Expenditures % Chg.

Innovative Medicine Capital Expenditures Common Size

MedTech Capital Expenditures

MedTech Capital Expenditures % Chg.

MedTech Capital Expenditures Common Size

Other Capital Expenditures

Other Capital Expenditures % Chg.

Other Capital Expenditures Common Size

Total Capital Expenditures

Total Capital Expenditures Common Size

Total Capital Expenditures % Chg.

Capital Expenditures

Consumer Health Income Before Tax

Consumer Health Income Before Tax % Chg.

Consumer Health Income Before Tax Common Size

Innovative Medicine Income Before Tax

Innovative Medicine Income Before Tax % Chg.

Innovative Medicine Income Before Tax Common Size

MedTech Income Before Tax

MedTech Income Before Tax % Chg.

MedTech Income Before Tax Common Size

Other EBT

Other EBT % Chg.

Other EBT Common Size

Total EBT

Total EBT Common Size

Total EBT % Chg.

Sales % Change due to Transactions

Sales % Change due to Transactions % Chg.

Sales % Change due to Price

Sales % Change due to Price % Chg.

Sales % Change due to Currency

Sales % Change due to Currency % Chg.

Key Performance Indicators

United States Revenue

United States Revenue % Chg.

United States Revenue Common Size

Europe Revenue

Europe Revenue % Chg.

Europe Revenue Common Size

Western Hemisphere ex-US Revenue

Western Hemisphere ex-US Revenue % Chg.

Western Hemisphere ex-US Revenue Common Size

Asia Pacific, Africa Revenue

Asia Pacific, Africa Revenue % Chg.

Asia Pacific, Africa Revenue Common Size

Total Revenue by Geography

Total Revenue by Geography Common Size

Total Revenue by Geography % Chg.

Revenue by Geography

Consumer Health Revenue

Consumer Health Revenue % Chg.

Consumer Health Revenue Common Size

Innovative Medicine Revenue

Innovative Medicine Revenue % Chg.

Innovative Medicine Revenue Common Size

MedTech Revenue

MedTech Revenue % Chg.

MedTech Revenue Common Size

Other Revenue

Other Revenue % Chg.

Other Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	Sep '25	Jun '25
Consumer Health Revenue	—	—
Innovative Medicine Revenue	15,563	15,202
MedTech Revenue	8,430	8,541
Other Revenue	—	—
Total Revenue	23,993	23,743

Revenue by Geography	Sep '25	Jun '25
United States Revenue	13,708	13,544
Europe Revenue	5,440	5,387
Western Hemisphere ex-US Revenue	1,231	1,206
Asia Pacific, Africa Revenue	3,614	3,606
Total Revenue by Geography	23,993	23,743

EBT	Sep '25	Jun '25
Consumer Health Income Before Tax	—	—
Innovative Medicine Income Before Tax	6,446	5,552
MedTech Income Before Tax	1,287	1,204
Other EBT	-240	-265
Total EBT	7,493	6,491